LiveVox Announces Fourth Quarter and Full Year 2021 Financial Results
LiveVox reported Q4 total revenue of $31.9 million, reflecting a year-over-year growth of 13.3%. Full-year revenue reached $119.2 million, up 16.3%. Q4 contract revenue also grew by 21.3% to $24.3 million, with full-year contract revenue at $90.5 million, marking a 25.9% increase.
However, the company's net loss widened to $11.8 million in Q4 and $103.2 million for the full year. Non-GAAP gross margin decreased to 59.0% for Q4 and 60.9% for the full year, indicating rising costs.
- Q4 total revenue increased 13.3% to $31.9 million.
- Full-year total revenue grew by 16.3% to $119.2 million.
- Contract revenue for Q4 rose 21.3% to $24.3 million.
- Full-year contract revenue up 25.9% to $90.5 million.
- Bookings increased 31% year-over-year.
- Net loss for Q4 widened to $11.8 million, up from $0.2 million year-over-year.
- Full-year net loss increased to $103.2 million from $4.6 million.
- Gross profit for Q4 decreased by 2.3% to $17.5 million.
- Non-GAAP gross margin fell to 59.0% in Q4 from 67.4% in the prior year.
Q4 total revenue year-over-year growth of
Q4 contract revenue year-over-year growth of
“We achieved another quarter of record total revenue at
Fourth Quarter 2021 Financial Highlights
-
Revenue1: Total revenue was
for the fourth quarter of 2021, up$31.9 million 13.3% compared to for the fourth quarter of 2020.$28.1 million -
Contract Revenue: Contract revenue was
for the fourth quarter of 2021, up$24.3 million 21.3% compared to for the fourth quarter of 2020.$20.1 million -
Gross Profit: Gross profit was
for the fourth quarter of 2021, down$17.5 million 2.3% compared to for the fourth quarter of 2020.$17.9 million -
Non-GAAP Gross Profit* and Non-GAAP Gross Margin*: Non-GAAP gross profit was
for the fourth quarter of 2021, down$18.8 million 0.8% compared to for the fourth quarter of 2020; Non-GAAP gross margin was$19.0 million 59.0% for the fourth quarter of 2021 after adjusting for stock-based compensation associated with restricted stock units and performance-based restricted stock units granted under the 2021 Equity Incentive Plan and depreciation and amortization, compared to67.4% for the fourth quarter of 2020. -
Net loss: Net loss was
for the fourth quarter of 2021, compared to net loss of$11.8 million for the fourth quarter of 2020.$0.2 million -
Adjusted EBITDA*: Adjusted EBITDA loss was
for the fourth quarter of 2021, compared to Adjusted EBITDA income of$7.0 million for the fourth quarter of 2020.$3.5 million
Full Year 2021 Financial Highlights
-
Revenue: Total revenue was
for the full year 2021, up$119.2 million 16.3% compared to for the full year 2020.$102.5 million -
Contract Revenue: Contract revenue was
for the full year 2021, up$90.5 million 25.9% compared to for the full year 2020.$71.9 million -
Gross Profit: Gross profit was
for the full year 2021, down$58.6 million 7.1% compared to for the full year 2020.$63.1 million -
Non-GAAP Gross Profit* and Non-GAAP Gross Margin*: Non-GAAP gross profit was
for the full year 2021, up$72.6 million 8.2% compared to for the full year 2020; Non-GAAP gross margin was$67.1 million 60.9% for the full year 2021 after adjusting for stock-based compensation, depreciation and amortization and long-term incentive compensation triggered by the closing of the merger withCrescent Acquisition Corp. during the year, compared to65.4% for the full year 2020. -
Net loss: Net loss was
for the full year 2021, compared to net loss of$103.2 million for the full year 2020.$4.6 million -
Adjusted EBITDA*: Adjusted EBITDA loss was
for the full year 2021, compared to Adjusted EBITDA income of$16.0 million for the full year 2020.$8.5 million
_______________________________
1 Total revenue is comprised of recurring subscription revenue and implementation revenue. Subscription revenue is comprised of contract revenue (revenue derived from usage committed under contract) and excess usage revenue (revenue derived from usage amounts higher than the minimum usage under contract).
* Additional information regarding the non-GAAP financial measures discussed in this release, including an explanation of these measures and how each is calculated, is included below under the heading “Non-GAAP Financial Measures.” A reconciliation of GAAP to non-GAAP financial measures has also been provided in the financial tables included below.
Business Outlook
In determining the financial guidance to provide to investors, the Company considered its recent business trends and financial results, current growth plans, strategic initiatives, global economic outlook and the continued uncertainty of COVID-19 and its potential impact on the Company’s results.
As such,
-
First Quarter 2022 Guidance:
-
Total revenue is expected to be in the range of
to$31.1 million , representing growth of$32.1 million 11% to15% year-over-year. -
Contract revenue is expected to be in the range of
to$24.4 million , representing growth of$24.9 million 18% to20% year-over-year. -
Excess usage revenue is expected to be in the range of
to$6.7 million , representing a decrease of$7.2 million 7% to flat year-over-year. -
Adjusted EBITDA loss is expected to be in the range of
to$8.7 million .$7.7 million
-
Total revenue is expected to be in the range of
-
Full Year 2022 Guidance:
-
Total revenue is now expected to be in the range of
to$140 million , representing growth of$142 million 17% to19% year-over-year. -
Contract revenue is now expected to be in the range of
to$109 million , representing growth of$111 million 20% to23% year-over-year. -
Excess usage revenue is expected to be in the range of
to$29 million , representing a growth of$34 million 1% to18% year-over-year. -
Adjusted EBITDA loss is expected to be in the range of
to$24 million .$26 million
-
Total revenue is now expected to be in the range of
Quarterly Conference Call
About
Forward-Looking Statements
Certain statements made in this release are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "would," "should," "future," "propose," "target," "goal," "objective," "outlook" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements relating to expected bookings, expected revenue and annual recurring revenue from contracts, growth expectations, and future financial results, including guidance. These statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside LiveVox’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Any such forward-looking statements are made pursuant to the safe harbor provisions available under applicable securities laws and speak only as of the date of this presentation.
Important factors, among others, that may affect actual results or outcomes include the inability to recognize the anticipated benefits of the business combination with
The information contained in this press release is summary information that is intended to be considered in the context of LiveVox’s
Consolidated Statements of Operations and Comprehensive Loss |
|||||||||||||||||||
(In thousands, except per share data) |
|||||||||||||||||||
|
For the three months
|
|
For the years ended |
||||||||||||||||
|
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
|
|
2019 |
|
|
(Unaudited) |
|
(Unaudited) |
|
|
|
|
|
|
||||||||||
Revenue |
$ |
31,866 |
|
|
$ |
28,131 |
|
|
$ |
119,231 |
|
|
$ |
102,545 |
|
|
$ |
92,755 |
|
Cost of revenue |
|
14,365 |
|
|
|
10,209 |
|
|
|
60,639 |
|
|
|
39,476 |
|
|
|
38,253 |
|
Gross profit |
|
17,501 |
|
|
|
17,922 |
|
|
|
58,592 |
|
|
|
63,069 |
|
|
|
54,502 |
|
Operating expenses |
|
|
|
|
|
|
|
|
|
||||||||||
Sales and marketing expense |
|
13,513 |
|
|
|
7,369 |
|
|
|
62,333 |
|
|
|
29,023 |
|
|
|
24,423 |
|
General and administrative expense |
|
7,535 |
|
|
|
4,586 |
|
|
|
44,694 |
|
|
|
14,291 |
|
|
|
16,938 |
|
Research and development expense |
|
8,083 |
|
|
|
5,500 |
|
|
|
52,562 |
|
|
|
20,160 |
|
|
|
16,607 |
|
Total operating expenses |
|
29,131 |
|
|
|
17,455 |
|
|
|
159,589 |
|
|
|
63,474 |
|
|
|
57,968 |
|
Loss from operations |
|
(11,630 |
) |
|
|
467 |
|
|
|
(100,997 |
) |
|
|
(405 |
) |
|
|
(3,466 |
) |
Interest expense, net |
|
814 |
|
|
|
964 |
|
|
|
3,732 |
|
|
|
3,890 |
|
|
|
3,320 |
|
Change in the fair value of warrant liability |
|
(567 |
) |
|
|
— |
|
|
|
(1,242 |
) |
|
|
— |
|
|
|
— |
|
Other expense (income), net |
|
(26 |
) |
|
|
78 |
|
|
|
(459 |
) |
|
|
154 |
|
|
|
(22 |
) |
Total other expense, net |
|
221 |
|
|
|
1,042 |
|
|
|
2,031 |
|
|
|
4,044 |
|
|
|
3,298 |
|
Pre-tax loss |
|
(11,851 |
) |
|
|
(575 |
) |
|
|
(103,028 |
) |
|
|
(4,449 |
) |
|
|
(6,764 |
) |
Provision for income taxes |
|
(19 |
) |
|
|
(332 |
) |
|
|
166 |
|
|
|
196 |
|
|
|
149 |
|
Net loss |
$ |
(11,832 |
) |
|
$ |
(243 |
) |
|
$ |
(103,194 |
) |
|
$ |
(4,645 |
) |
|
$ |
(6,913 |
) |
Comprehensive loss |
|
|
|
|
|
|
|
|
|
||||||||||
Net loss |
|
(11,832 |
) |
|
|
(243 |
) |
|
|
(103,194 |
) |
|
|
(4,645 |
) |
|
|
(6,913 |
) |
Other comprehensive (loss) income, net of tax |
|
|
|
|
|
|
|
|
|
||||||||||
Foreign currency translation adjustment |
|
(67 |
) |
|
|
111 |
|
|
|
(94 |
) |
|
|
12 |
|
|
|
(48 |
) |
Unrealized loss on marketable securities |
|
(177 |
) |
|
|
— |
|
|
|
(177 |
) |
|
|
— |
|
|
|
— |
|
Total other comprehensive (loss) income, net of tax |
|
(244 |
) |
|
|
111 |
|
|
|
(271 |
) |
|
|
12 |
|
|
|
(48 |
) |
Comprehensive loss |
$ |
(12,076 |
) |
|
$ |
(132 |
) |
|
$ |
(103,465 |
) |
|
$ |
(4,633 |
) |
|
$ |
(6,961 |
) |
Net loss per share |
|
|
|
|
|
|
|
|
|
||||||||||
Net loss per share—basic and diluted |
$ |
(0.13 |
) |
|
$ |
— |
|
|
$ |
(1.29 |
) |
|
$ |
(0.07 |
) |
|
$ |
(0.10 |
) |
Weighted average shares outstanding—basic and diluted |
|
91,466 |
|
|
|
66,637 |
|
|
|
79,964 |
|
|
|
66,637 |
|
|
|
66,637 |
|
Consolidated Balance Sheets |
|||||||
(In thousands, except per share data) |
|||||||
|
As of |
||||||
|
December
|
|
December
|
||||
ASSETS |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
47,217 |
|
|
$ |
18,098 |
|
Restricted cash, current |
|
100 |
|
|
|
1,368 |
|
Marketable securities, current |
|
7,226 |
|
|
|
— |
|
Accounts receivable, net |
|
20,128 |
|
|
|
13,817 |
|
Deferred sales commissions, current |
|
2,691 |
|
|
|
1,521 |
|
Prepaid expenses and other current assets |
|
6,151 |
|
|
|
2,880 |
|
Total Current Assets |
|
83,513 |
|
|
|
37,684 |
|
Property and equipment, net |
|
3,010 |
|
|
|
3,505 |
|
|
|
47,481 |
|
|
|
47,481 |
|
Intangible assets, net |
|
20,195 |
|
|
|
18,688 |
|
Operating lease right-of-use assets |
|
5,483 |
|
|
|
3,858 |
|
Deposits and other |
|
664 |
|
|
|
2,334 |
|
Marketable securities, net of current |
|
42,148 |
|
|
|
— |
|
Deferred sales commissions, net of current |
|
6,747 |
|
|
|
3,208 |
|
Restricted cash, net of current |
|
— |
|
|
|
100 |
|
Total Assets |
$ |
209,241 |
|
|
$ |
116,858 |
|
|
|
|
|
||||
LIABILITIES & STOCKHOLDERS’ EQUITY |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
6,490 |
|
|
$ |
3,521 |
|
Accrued expenses |
|
13,855 |
|
|
|
11,667 |
|
Deferred revenue, current |
|
1,307 |
|
|
|
1,140 |
|
Term loan, current |
|
561 |
|
|
|
1,440 |
|
Operating lease liabilities, current |
|
1,946 |
|
|
|
1,353 |
|
Finance lease liabilities, current |
|
26 |
|
|
|
392 |
|
Total current liabilities |
|
24,185 |
|
|
|
19,513 |
|
Long term liabilities: |
|
|
|
||||
Line of credit |
|
— |
|
|
|
4,672 |
|
Deferred revenue, net of current |
|
456 |
|
|
|
237 |
|
Term loan, net of current |
|
54,459 |
|
|
|
54,604 |
|
Operating lease liabilities, net of current |
|
4,046 |
|
|
|
3,088 |
|
Finance lease liabilities, net of current |
|
11 |
|
|
|
38 |
|
Deferred tax liability, net |
|
2 |
|
|
|
193 |
|
Warrant liability |
|
767 |
|
|
|
— |
|
Other long-term liabilities |
|
337 |
|
|
|
372 |
|
Total liabilities |
|
84,263 |
|
|
|
82,717 |
|
|
|
|
|
||||
Commitments and contingencies |
|
|
|
||||
Stockholders’ equity: |
|
|
|
||||
Preferred stock, |
|
— |
|
|
|
— |
|
Common stock, |
|
9 |
|
|
|
7 |
|
Additional paid-in capital |
|
253,468 |
|
|
|
59,168 |
|
Accumulated other comprehensive loss |
|
(477 |
) |
|
|
(206 |
) |
Accumulated deficit |
|
(128,022 |
) |
|
|
(24,828 |
) |
Total stockholders’ equity |
|
124,978 |
|
|
|
34,141 |
|
Total liabilities & stockholders’ equity |
$ |
209,241 |
|
|
$ |
116,858 |
|
Consolidated Statements of Cash Flows |
|||||||||||
(Dollars in thousands) |
|||||||||||
|
For the years ended |
||||||||||
|
|
2021 |
|
|
|
2020 |
|
|
|
2019 |
|
Operating activities: |
|
|
|
|
|
||||||
Net loss |
$ |
(103,194 |
) |
|
$ |
(4,645 |
) |
|
$ |
(6,913 |
) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |
|
|
|
|
|
||||||
Depreciation and amortization |
|
2,106 |
|
|
|
1,876 |
|
|
|
1,559 |
|
Amortization of identified intangible assets |
|
4,473 |
|
|
|
4,189 |
|
|
|
3,335 |
|
Amortization of deferred loan origination costs |
|
129 |
|
|
|
143 |
|
|
|
154 |
|
Amortization of deferred sales commissions |
|
2,052 |
|
|
|
1,259 |
|
|
|
889 |
|
Non-cash lease expense |
|
1,622 |
|
|
|
1,241 |
|
|
|
— |
|
Stock-based compensation expense |
|
3,905 |
|
|
|
556 |
|
|
|
— |
|
Equity incentive bonus |
|
32,626 |
|
|
|
— |
|
|
|
— |
|
Bad debt expense |
|
195 |
|
|
|
636 |
|
|
|
340 |
|
Loss on disposition of asset |
|
— |
|
|
|
54 |
|
|
|
— |
|
Deferred income tax benefit |
|
(191 |
) |
|
|
(127 |
) |
|
|
(288 |
) |
Change in the fair value of the warrant liability |
|
(1,242 |
) |
|
|
— |
|
|
|
— |
|
Changes in assets and liabilities |
|
|
|
|
|
||||||
Accounts receivable |
|
(5,810 |
) |
|
|
1,934 |
|
|
|
(4,439 |
) |
Other assets |
|
(3,297 |
) |
|
|
(2,296 |
) |
|
|
(379 |
) |
Deferred sales commissions |
|
(6,761 |
) |
|
|
(2,465 |
) |
|
|
(1,599 |
) |
Accounts payable |
|
3,403 |
|
|
|
1,015 |
|
|
|
966 |
|
Accrued expenses |
|
2,199 |
|
|
|
(1,666 |
) |
|
|
5,510 |
|
Deferred revenue |
|
385 |
|
|
|
579 |
|
|
|
655 |
|
Operating lease liabilities |
|
(1,664 |
) |
|
|
(1,281 |
) |
|
|
— |
|
Other long-term liabilities |
|
7 |
|
|
|
68 |
|
|
|
1,778 |
|
Net cash (used in) provided by operating activities |
|
(69,057 |
) |
|
|
1,070 |
|
|
|
1,568 |
|
Investing activities: |
|
|
|
|
|
||||||
Purchases of property and equipment |
|
(1,582 |
) |
|
|
(753 |
) |
|
|
(1,140 |
) |
Purchases of marketable securities |
|
(50,797 |
) |
|
|
— |
|
|
|
— |
|
Proceeds from sale of marketable securities |
|
1,250 |
|
|
|
— |
|
|
|
— |
|
Acquisition of businesses, net of cash acquired |
|
— |
|
|
|
(20 |
) |
|
|
(11,018 |
) |
Proceeds from asset acquisition, net of cash paid |
|
1,326 |
|
|
|
— |
|
|
|
— |
|
Net cash used in investing activities |
|
(49,803 |
) |
|
|
(773 |
) |
|
|
(12,158 |
) |
Financing activities: |
|
|
|
|
|
||||||
Proceeds from Merger and PIPE financing, net of cash paid |
|
159,691 |
|
|
|
— |
|
|
|
— |
|
Proceeds from borrowing on term loans |
|
— |
|
|
|
— |
|
|
|
13,900 |
|
Repayment on loan payable |
|
(1,816 |
) |
|
|
(1,152 |
) |
|
|
(844 |
) |
Proceeds from drawdown on line of credit |
|
— |
|
|
|
4,672 |
|
|
|
— |
|
Repayment of drawdown on line of credit |
|
(4,672 |
) |
|
|
— |
|
|
|
— |
|
Debt issuance costs |
|
(153 |
) |
|
|
— |
|
|
|
(265 |
) |
Payment of contingent consideration liability |
|
(5,969 |
) |
|
|
— |
|
|
|
— |
|
Repayments on finance lease obligations |
|
(392 |
) |
|
|
(752 |
) |
|
|
(1,038 |
) |
Net cash provided by financing activities |
|
146,689 |
|
|
|
2,768 |
|
|
|
11,753 |
|
Effect of foreign currency translation |
|
(78 |
) |
|
|
(12 |
) |
|
|
(62 |
) |
Net increase in cash, cash equivalents and restricted cash |
|
27,751 |
|
|
|
3,053 |
|
|
|
1,101 |
|
Cash, cash equivalents, and restricted cash beginning of period |
|
19,566 |
|
|
|
16,513 |
|
|
|
15,412 |
|
Cash, cash equivalents, and restricted cash end of period |
$ |
47,317 |
|
|
$ |
19,566 |
|
|
$ |
16,513 |
|
|
|
|
|
|
|
||||||
|
For the years ended |
|||||||
|
|
2021 |
|
|
2020 |
|
|
2019 |
Supplemental disclosure of cash flow information: |
|
|
|
|
|
|||
Interest paid |
$ |
3,484 |
|
$ |
3,768 |
|
$ |
3,329 |
Income taxes paid |
|
292 |
|
|
241 |
|
|
228 |
Supplemental schedule of noncash investing activities: |
|
|
|
|
|
|||
Equipment and software acquired under finance lease obligations |
$ |
— |
|
$ |
74 |
|
$ |
403 |
Additional right-of-use assets |
|
3,246 |
|
|
997 |
|
|
— |
|
|
|
|
|
|
|||
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets (dollars in thousands):
|
As of |
|||||||
|
|
2021 |
|
|
2020 |
|
|
2019 |
Cash and cash equivalents |
$ |
47,217 |
|
$ |
18,098 |
|
$ |
14,910 |
Restricted cash, current |
|
100 |
|
|
1,368 |
|
|
171 |
Restricted cash, net of current |
|
— |
|
|
100 |
|
|
1,432 |
Total cash, cash equivalents and restricted cash |
$ |
47,317 |
|
$ |
19,566 |
|
$ |
16,513 |
Non-GAAP Financial Measures
Management uses non-GAAP financial measures to evaluate operating performance. We believe non-GAAP financial measures provide useful information to investors and others to understand and evaluate our operating results in the same manner as our management and board of directors and allows for better comparison of financial results among our competitors.
Adjusted EBITDA
We monitor Adjusted EBITDA, a non-generally accepted accounting principle (“Non-GAAP”) financial measure, to analyze our financial results and believe that it is useful to investors, as a supplement to
Non-GAAP Gross Profit and Non-GAAP Gross Margin Percentage
Management uses Non-GAAP gross profit and Non-GAAP gross margin percentage to evaluate operating performance and to determine resource allocation among our various product offerings. We believe Non-GAAP gross profit and Non-GAAP gross margin percentage provide useful information to investors and others to understand and evaluate our operating results in the same manner as our management and board of directors and allows for better comparison of financial results among our competitors. Non-GAAP gross profit and Non-GAAP gross margin percentage may not be comparable to similarly titled measures of other companies because other companies may not calculate Non-GAAP gross profit and Non-GAAP gross margin percentage or similarly titled measures in the same manner as we do.
Please see tables below for a reconciliation of non-GAAP measures to the most directly comparable GAAP measures for the periods presented.
GAAP Net Loss to Adjusted EBITDA |
|||||||||||||||||||
(Dollars in thousands) |
|||||||||||||||||||
|
Three Months Ended
|
|
Years Ended |
||||||||||||||||
|
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
|
|
2019 |
|
|
(Unaudited) |
|
(Unaudited) |
|
|
|
|
|
|
||||||||||
Net loss |
$ |
(11,832 |
) |
|
$ |
(243 |
) |
|
$ |
(103,194 |
) |
|
$ |
(4,645 |
) |
|
$ |
(6,913 |
) |
Non-GAAP adjustments: |
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation and amortization |
|
1,745 |
|
|
|
1,546 |
|
|
|
6,579 |
|
|
|
6,065 |
|
|
|
4,894 |
|
Long-term equity incentive bonus and stock-based compensation expenses |
|
2,455 |
|
|
|
574 |
|
|
|
74,489 |
|
|
|
1,323 |
|
|
|
9,182 |
|
Interest expense, net |
|
814 |
|
|
|
964 |
|
|
|
3,732 |
|
|
|
3,890 |
|
|
|
3,320 |
|
Change in the fair value of warrant liability |
|
(567 |
) |
|
|
— |
|
|
|
(1,242 |
) |
|
|
— |
|
|
|
— |
|
Other expense (income), net |
|
(26 |
) |
|
|
78 |
|
|
|
(460 |
) |
|
|
154 |
|
|
|
(22 |
) |
Acquisition and financing related fees and expenses |
|
16 |
|
|
|
— |
|
|
|
1,537 |
|
|
|
25 |
|
|
|
1,664 |
|
Transaction-related costs |
|
429 |
|
|
|
707 |
|
|
|
2,263 |
|
|
|
707 |
|
|
|
— |
|
|
|
— |
|
|
|
179 |
|
|
|
135 |
|
|
|
781 |
|
|
|
732 |
|
Other non-recurring expenses |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
249 |
|
Provision for income taxes |
|
(19 |
) |
|
|
(332 |
) |
|
|
166 |
|
|
|
196 |
|
|
|
149 |
|
Adjusted EBITDA |
$ |
(6,985 |
) |
|
$ |
3,473 |
|
|
$ |
(15,995 |
) |
|
$ |
8,496 |
|
|
$ |
13,255 |
|
GAAP Gross Profit to Adjusted Gross Profit |
|||||||||||||||||||
(Dollars in thousands) |
|||||||||||||||||||
|
Three Months Ended
|
|
Years Ended |
||||||||||||||||
|
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
|
|
2019 |
|
|
(Unaudited) |
|
(Unaudited) |
|
|
|
|
|
|
||||||||||
Gross profit |
$ |
17,501 |
|
|
$ |
17,922 |
|
|
$ |
58,592 |
|
|
$ |
63,069 |
|
|
$ |
54,502 |
|
Depreciation and amortization |
|
991 |
|
|
|
962 |
|
|
|
3,776 |
|
|
|
3,826 |
|
|
|
3,130 |
|
Long-term equity incentive bonus and stock-based compensation expenses |
|
320 |
|
|
|
81 |
|
|
|
10,197 |
|
|
|
180 |
|
|
|
1,007 |
|
Other non-recurring expenses |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
211 |
|
Non-GAAP gross profit |
$ |
18,812 |
|
|
$ |
18,965 |
|
|
$ |
72,565 |
|
|
$ |
67,075 |
|
|
$ |
58,850 |
|
Non-GAAP gross margin % |
|
59.0 |
% |
|
|
67.4 |
% |
|
|
60.9 |
% |
|
|
65.4 |
% |
|
|
63.4 |
% |
The following table presents the long-term equity incentive bonus included in Company’s results of operations for the three months ended
|
Three Months Ended
|
|
Years Ended |
|||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|
2019 |
|||||
|
(Unaudited) |
|
(Unaudited) |
|
|
|
|
|
|
|||||
Cost of revenue |
$ |
2 |
|
$ |
73 |
|
$ |
9,697 |
|
$ |
123 |
|
$ |
1,007 |
Sales and marketing expense |
|
4 |
|
|
85 |
|
|
18,405 |
|
|
277 |
|
|
1,874 |
General and administrative expense |
|
— |
|
|
302 |
|
|
18,594 |
|
|
336 |
|
|
4,420 |
Research and development expense |
|
2 |
|
|
28 |
|
|
23,888 |
|
|
31 |
|
|
1,881 |
Total long-term equity incentive bonus |
$ |
8 |
|
$ |
488 |
|
$ |
70,584 |
|
$ |
767 |
|
$ |
9,182 |
The following table presents the stock-based compensation expenses included in Company’s results of operations for the three months ended
|
Three Months Ended
|
|
Years Ended |
||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|
2019 |
||||
|
(Unaudited) |
|
(Unaudited) |
|
|
|
|
|
|
||||
Cost of revenue |
|
|
$ |
8 |
|
$ |
500 |
|
$ |
57 |
|
$ |
— |
Sales and marketing expense |
553 |
|
|
18 |
|
|
865 |
|
|
113 |
|
|
— |
General and administrative expense |
679 |
|
|
42 |
|
|
1,169 |
|
|
273 |
|
|
— |
Research and development expense |
897 |
|
|
18 |
|
|
1,371 |
|
|
113 |
|
|
— |
Total stock-based compensation |
|
|
$ |
86 |
|
$ |
3,905 |
|
$ |
556 |
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220310005914/en/
Investor Contacts:
awaadt@livevox.com
livevoxIR@icrinc.com
Press contacts:
nbandy@livevox.com
livevoxPR@icrinc.com
Source:
FAQ
What were LiveVox's Q4 earnings results for LVOX?
How did LiveVox perform in 2021?
What is LiveVox's guidance for 2022?